Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by account15on Jun 07, 2019 2:57pm
76 Views
Post# 29807001

RE:Up 32,000% since I told u to buy Bitcoin

RE:Up 32,000% since I told u to buy Bitcoin
This is my first comment since telesta days. I must admit that I was wrong and as crazy as your ideas were regarding crypto and weed, I think if Greame was to stay and those 2 did not show up, perhaps bioniche would still exist today. Also they had 50 million, and a plant in Belleville. If they converted into weed stock , we all would have been retired. I never thought that PLI would be screwed . I might buy it but at less than a cent. It will be consolidated ,and it will drop. I did not follow pli too closely, but if someone can explain to me : their phase 3 was very small. Are they going to get approved\?? -sample size in their phase 2/3 was extremely small. that was partly why telesta (even with 127 bodies) was rejected during that fda meeting. Also what is the potential market that they aim at , and their competition if exists. thanks
Bullboard Posts